A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ATII / angiotensin II

[Related PubMed/MEDLINE]
Total Number of Papers: 240
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ATII  (>> Co-occurring Abbreviation)
Long Form:   angiotensin II
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy. DM2, SGLT2I
2019 A Retrospective Review of Angiotensin II Use in Adult Patients With Refractory Distributive Shock. ---
2019 Angiotensin II in septic shock. ---
2019 Angiotensin II: A New Vasopressor for the Treatment of Distributive Shock. ---
2019 Profibrotic effects of angiotensin II and transforming growth factor beta on feline kidney epithelial cells. alpha-SMA, AT1, CRFK, CTGF, EMT, TGF-beta1, TN-C, TSP-1
2018 A Blast From the Past: Revival of Angiotensin II for Vasodilatory Shock. FDA
2018 Action Potential Prolongation, beta-Adrenergic Stimulation, and Angiotensin II as Co-factors in Sarcoplasmic Reticulum Instability. AP, APD, CMs, ISO, ISO, ITI, SR
2018 alpha1AMPK deletion in myelomonocytic cells induces a pro-inflammatory phenotype and enhances angiotensin II-induced vascular dysfunction. AMPK, CCR2
2018 Angiotensin II Brings More Questions Than Answers. ---
10  2018 Angiotensin II Use in Refractory Multisystem Shock: A Case Report. ED, ICU
11  2018 Angiotensin receptor blockade attenuates cholangiocarcinoma cell growth by inhibiting the oncogenic activity of Yes-associated protein. ARBs, CCA, YAP
12  2018 Clinical significance of increased urotensin II levels in acute myocardial infarction. AMI, MMP-2, NT-BNP, PCI, UII
13  2018 Crosstalk between FGF23- and angiotensin II-mediated Ca2+ signaling in pathological cardiac hypertrophy. FGF23, HF, LVH, NRVMs, RAAS
14  2018 Investigating the cardiac pathology of SCO2-mediated hypertrophic cardiomyopathy using patients induced pluripotent stem cell-derived cardiomyocytes. BRV, DADs, EB, HCM, iPSC
15  2018 The Angiotensin II Type 1 Receptor Antagonist Losartan Affects NHE1-Dependent Melanoma Cell Behavior. AT1, AT2, NHE1
16  2018 The Therapeutic Potential of Angiotensin-converting Enzyme and Angiotensin Receptor Inhibitors in the Treatment of Colorectal Cancer: Rational Strategies and Recent Progress. ACEIs, ARIs, AT, CRC, IGF-1, miRs, VEGF
17  2017 Acute improvement of endothelial functions after oral ingestion of isohumulones, bitter components of beer. FMD, HAECs, IHE, ROS
18  2017 Aldosterone-Sensing Neurons in the NTS Exhibit State-Dependent Pacemaker Activity and Drive Sodium Appetite via Synergy with Angiotensin II Signaling. SFO
19  2017 Enhanced peripheral dopamine impairs post-ischemic healing by suppressing angiotensin receptor type 1 expression in endothelial cells and inhibiting angiogenesis. AT1R, HLI, RAS
20  2017 Redox regulation of cardiovascular inflammation - Immunomodulatory function of mitochondrial and Nox-derived reactive oxygen and nitrogen species. ---
21  2017 [Effect of an angiotensin-converting-enzyme inhibitor on the plasma concentration of cytokines and vasoactive molecules in patients with coronary heart disease and hypertension]. ACE, CHD, ET-1, FC, IL, RAAS
22  2016 Beneficial effects of combined ursodeoxycholic acid and angiotensin-II type 1 receptor blocker on hepatic fibrogenesis in a rat model of nonalcoholic steatohepatitis. Ac-HSC, CDAA, LPS, NASH, TGF, UDCA, ZO-1
23  2016 Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Prothrombotic Processes and Myocardial Infarction Risk. ---
24  2016 PGC-1alpha dictates endothelial function through regulation of eNOS expression. ERRalpha, PGC-1alpha
25  2016 Pharmacodynamic Impact of Carboxylesterase 1 Gene Variants in Patients with Congestive Heart Failure Treated with Angiotensin-Converting Enzyme Inhibitors. AT-I, CES1, CHF, CIs, LSM
26  2016 Serum levels of renin, angiotensin-converting enzyme and angiotensin II in patients treated by surgical excision, propranolol and captopril for problematic proliferating infantile haemangioma. ACE, IH, PRA, RAS
27  2015 A mouse model of heart failure with preserved ejection fraction due to chronic infusion of a low subpressor dose of angiotensin II. HF, LV
28  2015 Effect of topical propranolol gel on plasma renin, angiotensin II and vascular endothelial growth factor in superficial infantile hemangiomas. IHs, VEGF
29  2015 Losartan reduces oxidative damage to renal DNA and conserves plasma antioxidant capacity in diabetic rats. 8-oxodGuo, Adp, FRAP, ROS, STZ
30  2015 Matrix-assisted laser desorption/ionisation (MALDI) TOF analysis identifies serum angiotensin II concentrations as a strong predictor of all-cause and breast cancer (BCa)-specific mortality following breast surgery. BCa, MALDI
31  2015 The Higher Response of Vascular Endothelial Growth Factor and Angiotensin-II to Human Chorionic Gonadotropin in Women with Polycystic Ovary Syndrome. hCG, OHSS, PCOS, VEGF
32  2015 [Vascular reactivity and receptor expression of endogenous vasoconstrictor in rats with alcoholic cardiomyopathy and insulation stress]. AVP, ET-1, GR, NA
33  2014 Improved gastric emptying in diabetic rats by irbesartan via decreased serum leptin and ameliorated gastric microcirculation. DG, ET, GER, NOS
34  2014 Interference of angiotensin II and enalapril with hepatic blood flow regulation. HABR
35  2014 Interplay of NK cells and monocytes in vascular inflammation and myocardial infarction. MI
36  2014 Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study. MAP
37  2014 Molecular mechanisms of the crosstalk between mitochondria and NADPH oxidase through reactive oxygen species-studies in white blood cells and in animal models. eNOS, mPTP, mtROS, NOX
38  2014 Obligatory role of intraluminal O2- in acute endothelin-1 and angiotensin II signaling to mediate endothelial dysfunction and MAPK activation in guinea-pig hearts. ET-1, NOX, XO
39  2014 The effect of intra-arterial angiotensin II on the hepatic tumor to non-tumor blood flow ratio for radioembolization: a systematic review. ---
40  2014 Therapeutic effects of the direct renin inhibitor, aliskiren, on non-alcoholic steatohepatitis in fatty liver Shionogi ob/ob male mice. DRI, FLS, NASH, PRA, RAS
41  2013 Angiotensin II-induced vascular dysfunction depends on interferon-gamma-driven immune cell recruitment and mutual activation of monocytes and NK-cells. IFN-gamma, NK, T-bet
42  2013 CD40L contributes to angiotensin II-induced pro-thrombotic state, vascular inflammation, oxidative stress and endothelial dysfunction. CD40L, FACS, ROS
43  2013 Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis. Ac-HSC, MyD88, NF-kappaB, TGF-beta, TLR4
44  2013 Direct renin inhibitor, aliskiren, attenuates the progression of non-alcoholic steatohepatitis in the rat model. Ac-HSC, CDAA, DRI, GST-P, NASH, RAS, TGF-beta1, VEGF
45  2013 Dual blockade of angiotensin-II and aldosterone suppresses the progression of a non-diabetic rat model of steatohepatitis. Ac-HSC, ACEI, ALD, CDAA, GST-P, SAB
46  2013 No evidence for the expression of renin-angiotensin-aldosterone system in otosclerotic stapes footplates. ACE, AT-IIR, HE, IFA, RAA, SNP
47  2013 Peroxisome proliferator-activated receptor gamma, coactivator 1alpha deletion induces angiotensin II-associated vascular dysfunction by increasing mitochondrial oxidative stress and vascular inflammation. PGC-1alpha
48  2013 Thirst response to acute hypovolaemia in healthy women and women prone to vasovagal syncope. LBNP, VVS
49  2012 Angiotensin II protects primary rat hepatocytes against bile salt-induced apoptosis. ARBs, GCDCA, HSCs, TLC-S
50  2012 Angiotensin II-mediated left ventricular abnormalities in chronic kidney disease. CKD, LV, RAS
51  2012 Effect of inter-renal aortic coarctation-induced hypertension on function and expression of vascular alpha(1A)- and alpha(1D)-adrenoceptors. AC7, BMY, RS, SO
52  2012 Glomerular repair retardation via blocking of angiotensin II type 1a receptor pathway in a mouse glomerulonephritis model. HSV, VEGF
53  2012 On the different roles of AT1 and AT2 receptors in stretch-induced changes of connexin43 expression and localisation. AT-R, CMS, Cx43
54  2012 Relaxant effect of a water soluble carbon monoxide-releasing molecule (CORM-3) on spontaneously hypertensive rat aortas. CO, ET-1, NO, SHR, WKY
55  2012 Restoring nitric oxide cytosolic calcium regulation by cyclic guanosine monophosphate protein kinase I alpha transfection in coronary endothelial cells of spontaneously hypertensive rats. GMP, NO, SHR, WKY
56  2011 Angiotensin II Inhibits Insulin Binding to Endothelial Cells. IR
57  2011 Angiotensin II type 1 receptor, but no type 2 receptor, interferes with the insulin-induced nitric oxide production in HUVECs. HUVECs, NO
58  2011 Angiotensin II-mediated Nrf2 down-regulation: a potential causing factor for renal fibrosis? EMT, Nrf2
59  2011 Ectopic fat storage, insulin resistance, and hypertension. ACE, RAAS
60  2011 Impact of renin-angiotensin system in hepatocellular carcinoma. ACEI, ALD, BCAA, HCC, IFN, IR, RAS, SAB, VEGF, VK
61  2011 Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction. ---
62  2011 Pravastatin normalises peripheral cardiac sympathetic hyperactivity in the spontaneously hypertensive rat. HR, NOS, SHR
63  2011 Suppression of Nrf2 signaling by angiotensin II in murine renal epithelial cells. alpha-SMA, ATF3, GCL, Nrf2, ROS
64  2011 The renin-angiotensin system, blood pressure, and heart structure in patients with hereditary vitamin D-resistance rickets (HVDRR). ACE, HVDRR, HVDRR, PRA, PTH, RAS, VDR-KO
65  2011 The role of bone morphogenetic protein-5 (BMP-5) in human nephrosclerosis. BMP-5, EMT, TGF-ss, TNF-alpha
66  2011 [Multicenter trial of olmesartan. Main results]. ACE, OM
67  2011 [The significance of generic valsartan in the treatment of patients]. ARB, RAAS
68  2010 Diuretics and diabetes incidence--an appeal against the reluctance to prescribe a medication that is safe and proven. ACE
69  2010 Human embryonic stem cell-derived cardiomyocytes can mobilize 1,4,5-inositol trisphosphate-operated [Ca2+]i stores: the functionality of angiotensin-II/endothelin-1 signaling pathways. ET-1, hESC-CM
70  2010 Protective effects of intranasal losartan in the APP/PS1 transgenic mouse model of Alzheimer disease. ARBs, AT1-R, CNS, GM-CSF, IL-12, PD, RAS
71  2010 Role of angiotensin II in liver fibrosis-induced portal hypertension and therapeutic implications. RAA
72  2010 The effects of the selective mineralocorticoid receptor antagonist eplerenone on hepatic fibrosis induced by bile duct ligation in rat. 4-HNE, BDL, CTGF, MMP-13, SMA, TGF-beta1, TIMP-1
73  2009 Activation of MMP8 and MMP13 by angiotensin II correlates to severe intra-plaque hemorrhages and collagen breakdown in atherosclerotic lesions with a vulnerable phenotype. IPH
74  2009 Cell-cell bond modulates vascular smooth muscle cell responsiveness to Angiotensin II. AT1R, Cav-1, VSMC
75  2009 Isolation and characterization of resident mesenchymal stem cells in human glomeruli. alpha-SMA, Gl-MSC, MSC, vWF
76  2009 Losartan counteracts the hyper-reactivity to angiotensin II and ROCK1 over-activation in aortas isolated from streptozotocin-injected diabetic rats. DL, PHE, STZ rats
77  2009 Pals-associated tight junction protein functionally links dopamine and angiotensin II to the regulation of sodium transport in renal epithelial cells. PATJ
78  2009 Strain-dependent differences of restraint stress-induced hypertension in WKY and SHR. BP, HR, NE, SHR, TC, WKY
79  2008 1,4,5-Inositol trisphosphate-operated intracellular Ca(2+) stores and angiotensin-II/endothelin-1 signaling pathway are functional in human embryonic stem cell-derived cardiomyocytes. ET-1, hESC-CM
80  2008 Secondary pulmonary hypertension: haemodynamic effects of torasemide versus furosemide. ---
81  2008 The role of angiotensin II type 1a receptor on intestinal epithelial cells following small bowel resection in a mouse model. ACE, ATII-1a, EC, SBR
82  2007 Angiotensin II receptor blocker inhibits neointimal hyperplasia through regulation of smooth muscle-like progenitor cells. AT2R, BM-MNCs, GFP, PB-MNCs, SM
83  2007 Angiotensin receptor type 1 blockade in astroglia decreases hypoxia-induced cell damage and TNF alpha release. APC, AT1-R, ATR, HC, NC
84  2007 Aqueous humor dynamics in monkeys in response to the kappa opioid agonist bremazocine. BRE, IOP, MAP, nor-BNI
85  2007 Blockade of renin-angiotensin system in antifibrotic therapy. Ac-HSC, ACE, ARB, IFN, RAS, TGF-beta, TIMP-1
86  2007 Colchicine, a microtubule depolymerizing agent, inhibits myocardial apoptosis in rats. ---
87  2007 Different reactivity of the proximal and distal segments of the radial artery to vasoconstrictors in patients undergoing coronary artery bypass grafting. CABG, ET-3, PE, PGF2, RA
88  2007 Differential roles of Angiotensinogen and Angiotensin Receptor type 1 polymorphisms in breast cancer risk. AGT, AGTR1, HR
89  2007 Intrahippocampal microinjection of an exquisitely low dose of ouabain mimics NaCl loading and stimulates a bufadienolide Na/K-ATPase inhibitor. BP, DSS, EOU, SON
90  2007 Renin-angiotensin system inhibitors as therapeutic alternatives in the treatment of chronic liver diseases. ACEI, ARB, HCC, RAS, VEGF
91  2007 Reperfusion kinase phosphorylation is essential but not sufficient in the mediation of pharmacological preconditioning: Characterisation in the bi-phasic profile of early and late protection. ERK, PPC
92  2007 Time-dependent changes in pulmonary vascular responses to acute hypoxia during and after cold exposure in rats. ---
93  2006 A case of ACTH-independent bilateral macronodular adrenal hyperplasia and severe congestive heart failure. AIMAH, CHF, CS, MC2R
94  2006 Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis development. CDAA, HSC, PKC, VEGF
95  2006 Angiotensin-II combined intra-arterial chemotherapy for locally advanced bladder cancer: a case series study at a single institution. IAC
96  2006 Differential effects of RAS inhibitors associated with ACE gene polymorphisms in type 2 diabetic nephropathy. ACE, ACEI, RAS
97  2006 Effect of fosinopril in children with steroid-resistant idiopathic nephrotic syndrome. ACE, RAS, SRINS
98  2006 Impaired drinking response in histamine H3 receptor knockout mice following dehydration or angiotensin-II challenge. H3Rs, i.c.v, R-alpha-MeHA
99  2006 Inducible platelet-derived growth factor D-chain expression by angiotensin II and hydrogen peroxide involves transcriptional regulation by Ets-1 and Sp1. PDGF-D, SMCs
100  2006 Systemic inhibition of the angiotensin-converting enzyme limits lipopolysaccharide-induced lung neutrophil recruitment through both bradykinin and angiotensin II-regulated pathways. ACE, RAS